Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Dec 12, 2022
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-09+44,000→ 63,771 total - Award
Stock Option (right to buy)
2022-12-09+66,000→ 66,000 totalExercise: $5.09Exp: 2032-12-09→ Common Stock (66,000 underlying)
Footnotes (2)
- [F1]Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of December 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
- [F2]Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of December 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.